{"id":"https://openalex.org/W4388048041","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0305","title":"305 CAR positive cell selection: A versatile approach to purify CAR-T cells using anti-linker monoclonal antibodies attached to cleavable magnetic beads","display_name":"305 CAR positive cell selection: A versatile approach to purify CAR-T cells using anti-linker monoclonal antibodies attached to cleavable magnetic beads","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388048041","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0305"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0305","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0305","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0305","pdf_url":"https://jitc.bmj.com/content/11/Suppl_1/A348.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/11/Suppl_1/A348.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031878599","display_name":"Amrik J. Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134725","display_name":"Cell Signaling Technology (United States)","ror":"https://ror.org/03k4zc121","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amrik Singh","raw_affiliation_strings":["Cell Signaling Technology Inc., Danvers, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Signaling Technology Inc., Danvers, MA, USA","institution_ids":["https://openalex.org/I4210134725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068978826","display_name":"Sarah L\u2019Heureux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134725","display_name":"Cell Signaling Technology (United States)","ror":"https://ror.org/03k4zc121","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah L\u2019Heureux","raw_affiliation_strings":["Cell Signaling Technology Inc., Danvers, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Signaling Technology Inc., Danvers, MA, USA","institution_ids":["https://openalex.org/I4210134725"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055799584","display_name":"Jeremy Fisher","orcid":"https://orcid.org/0000-0002-7296-586X","observed_orcids":["https://orcid.org/0000-0002-7296-586X"]},"institutions":[{"id":"https://openalex.org/I4210134725","display_name":"Cell Signaling Technology (United States)","ror":"https://ror.org/03k4zc121","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy Fisher","raw_affiliation_strings":["Cell Signaling Technology Inc., Danvers, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Signaling Technology Inc., Danvers, MA, USA","institution_ids":["https://openalex.org/I4210134725"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210134725"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A348","last_page":"A348"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.7590000033378601},{"id":"https://openalex.org/keywords/immunoaffinity-purification","display_name":"immunoaffinity purification","score":0.7749999761581421},{"id":"https://openalex.org/keywords/biotinylated-antibodies","display_name":"biotinylated antibodies","score":0.7350000143051147},{"id":"https://openalex.org/keywords/streptavidin-coated-magnetic-beads","display_name":"streptavidin-coated magnetic beads","score":0.7590000033378601},{"id":"https://openalex.org/keywords/t-cell-engineering","display_name":"T cell engineering","score":0.550000011920929},{"id":"https://openalex.org/keywords/solid-tumor-immunotherapy","display_name":"solid tumor immunotherapy","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C204628709","wikidata":"https://www.wikidata.org/wiki/Q864854","display_name":"Biotinylation","level":2,"score":0.8872051239013672},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7585673332214355},{"id":"https://openalex.org/C2776190903","wikidata":"https://www.wikidata.org/wiki/Q421817","display_name":"Streptavidin","level":3,"score":0.6581263542175293},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.6445124745368958},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.6322147250175476},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.47209542989730835},{"id":"https://openalex.org/C2776967038","wikidata":"https://www.wikidata.org/wiki/Q290671","display_name":"Single-chain variable fragment","level":4,"score":0.4305022358894348},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4214162528514862},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4148416817188263},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3711146116256714},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3374990224838257},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3122375011444092},{"id":"https://openalex.org/C2778204606","wikidata":"https://www.wikidata.org/wiki/Q181354","display_name":"Biotin","level":2,"score":0.2952718138694763},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.28828883171081543},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1914748251438141},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14620912075042725},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.13555863499641418},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.11781436204910278},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.057332366704940796},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0305","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0305","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0305","pdf_url":"https://jitc.bmj.com/content/11/Suppl_1/A348.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:cfa46c1888d04b25a6a8605e67ab5f55","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/cfa46c1888d04b25a6a8605e67ab5f55","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0305","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0305","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0305","pdf_url":"https://jitc.bmj.com/content/11/Suppl_1/A348.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388048041.pdf","grobid_xml":"https://content.openalex.org/works/W4388048041.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393092574","https://openalex.org/W4393528900","https://openalex.org/W4362543733","https://openalex.org/W4416313870","https://openalex.org/W4413831506","https://openalex.org/W4404064008","https://openalex.org/W2554060291","https://openalex.org/W4415899023","https://openalex.org/W4409563412","https://openalex.org/W7148888212"],"abstract_inverted_index":{"Background":[0],"Chimeric":[1],"Antigen":[2],"Receptor":[3],"(CAR)-T":[4],"cell":[5,42,48,78,215,316,342],"therapy":[6],"is":[7,70],"a":[8,37,71,91,117,121,137,267,271,302,306,340],"powerful":[9],"new":[10],"modality":[11],"for":[12,23,73,142,355],"cancer":[13],"immunotherapy.":[14],"To":[15],"date,":[16],"much":[17],"of":[18,26,40,65,116,145,205,225,245,250,278,294,310,335],"the":[19,24,143,240,292,333,345],"success":[20],"has":[21],"been":[22],"treatment":[25],"hematological":[27],"malignancies.":[28],"Effective":[29],"strategies":[30],"targeting":[31,179],"solid":[32],"tumors,":[33],"however,":[34],"will":[35,155],"require":[36],"deeper":[38],"understanding":[39],"CAR-T":[41,315],"biology.":[43],"Many":[44],"commercially":[45],"available":[46],"CAR":[47,63,77,146,164,170,201,237,263,311],"purification":[49,79,293],"reagents":[50,80],"either":[51,114,180,266,301],"lack":[52],"specificity":[53,206,277],"or":[54,120,182,270,305],"are":[55,105,352],"not":[56],"versatile":[57,256],"in":[58,128,190,325,329],"their":[59],"ability":[60],"to":[61,85,100,158,198,259],"purify":[62,200],"cells":[64,89,166,228,238,252,264,296,347],"differing":[66],"antigen":[67,312],"specificity.":[68,247,313],"There":[69],"need":[72,334],"specific,":[74],"yet":[75,151],"flexible":[76],"that":[81,104,230],"can":[82,321],"be":[83,323],"used":[84,189,324],"research":[86],"and":[87,126,160,177,188,207,217,233,282,331,362],"engineer":[88],"with":[90,192,285],"better":[92],"therapeutic":[93],"index.":[94],"Recombinant":[95],"rabbit":[96],"monoclonal":[97,174,279],"antibodies":[98],"specific":[99,150],"two":[101],"linker":[102,171,242,269,273,304,308],"sequences":[103],"commonly":[106],"integrated":[107],"into":[108],"single-chain":[109],"variable":[110],"fragment":[111],"(scFv)-based":[112],"CARs,":[113],"repeats":[115],"Gly4Ser":[118,181,268,303],"peptide":[119],"Whitlow/218":[122,183,272],"peptide,":[123],"were":[124,186,253],"generated":[125],"characterized":[127],"multiple":[129],"applications":[130,357],"including":[131],"immunoaffinity":[132,140,199,257],"purification.":[133],"Here,":[134],"we":[135],"describe":[136],"magnetic":[138,196,289],"bead-based":[139],"method":[141,258,351],"enrichment":[144],"expressing":[147,165,202,297],"cells.":[148,203],"This":[149],"broadly":[152],"applicable":[153],"strategy":[154],"enable":[156],"researchers":[157],"expand":[159],"characterize":[161],"viable,":[162],"bead-free":[163],"containing":[167,239,265,300],"common":[168],"scFv-based":[169,298],"sequences.Methods":[172],"The":[173,276,314],"antibodies,":[175,280],"E7O2V":[176,232,281],"E3U7Q":[178,234],"linkers,":[184],"respectively,":[185],"biotinylated":[187,231],"concert":[191],"cleavable":[193],"streptavidin":[194],"coated":[195],"beads":[197,290],"Validation":[204],"versatility":[208],"was":[209,274],"performed":[210],"using":[211],"non-transduced":[212,251],"versus":[213],"CAR-transduced":[214],"lines":[216],"primary":[218],"human":[219],"T":[220],"cells.Results":[221],"Flow":[222],"cytometric":[223],"analysis":[224],"bead-free,":[226],"purified":[227,346],"revealed":[229],"could":[235],"enrich":[236],"appropriate":[241],"sequence,":[243],"independently":[244],"scFv":[246],"No":[248],"carryover":[249],"observed.Conclusions":[254],"A":[255],"positively":[260],"select":[261],"viable":[262],"developed.":[275],"E3U7Q,":[283],"combined":[284],"gentle":[286],"separation":[287],"from":[288,349],"enabled":[291],"live":[295],"CARs":[299],"Whitlow":[307],"regardless":[309],"selection":[317],"approach":[318],"demonstrated":[319],"here":[320],"potentially":[322,353],"an":[326],"automated":[327],"fashion,":[328],"high-throughout":[330],"without":[332],"expensive":[336],"equipment":[337],"such":[338,358],"as":[339,359],"flow":[341,363],"sorter.":[343],"Lastly,":[344],"obtained":[348],"this":[350],"suitable":[354],"downstream":[356],"single-cell":[360],"RNAseq":[361],"cytometry.":[364]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}